HanAll Biopharma
Asia, Seoul-t'ukpyolsi, South Korea, Seoul'%3e%3cg id='b'%3e%3cpath id='a' stroke='%23000' stroke-width='2' d='M-6-25H6m-12 3H6m-12 3H6'/%3e%3cuse xlink:href='%23a' y='44'/%3e%3c/g%3e%3cpath stroke='%23fff' d='M0 17v10'/%3e%3ccircle r='12' fill='%23cd2e3a'/%3e%3cpath fill='%230047a0' d='M0-12A6 6 0 0 0 0 0a6 6 0 0 1 0 12 12 12 0 0 1 0-24z'/%3e%3c/g%3e%3cg transform='rotate(-123.69)'%3e%3cuse xlink:href='%23b'/%3e%3cpath stroke='%23fff' d='M0-23.5v3M0 17v3.5m0 3v3'/%3e%3c/g%3e%3c/svg%3e)
Description
HanAll Biopharma World’s Best Bio Pharma for R&D of New Innovative Medicine Respectful Pharmaceutical Company.
Investor Profile
HanAll Biopharma has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Genetics, Health Care.
Stage Focus
- Series Unknown (100%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Genetics
- Health Care
- Life Science
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
